Lower costs. Improve outcomes. Advance quality of care.
Drug discovery. Clinical trial design. Post-marketed safety review.
Lower medical costs. Improve patient outcomes. Advance quality of care.
Predictive modeling. FDA action alerting. Comprehensive due diligence.
Making drug safety information accessible through a proprietary 17-step algorithmic process that refines the FDA Adverse Events Reporting System (FAERS).
Learn More »
Making drug safety information actionable through an algorithmic scoring model that ranks and compares medications based on post-marketed safety signals.
Making drug safety information predictable through a statistical signaling model that provides preemptive alerts to potential FDA communications and actions.